Health
Please Explain podcast: mutant coronavirus strains causing headaches for vaccine manufacturers – The Sydney Morning Herald
In today’s episode of Please Explain Daily, Nathanael Cooper and science reporter Liam Mannix discuss what these mutant strains are and how pharmaceutical companies…
Early stage clinical trial data from coronavirus vaccine manufacturers Johnson & Johnson and Novavax released late last week showed a decreased efficacy against the emerging South African variant of the virus.
The trials showed the vaccines provided between 49 and 57 per cent protection against the strain.
Australia will begin distributing vaccines at the end of this month from Pfizer, who is still awaiting fresh data on its ability to combat this new variant of COVID-19.
As the virus continues…
-
General11 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Noosa News17 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General14 hours agoTrump mulling whether to fire US Fed chair Powell
-
General13 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for